Robertson Lindsie A, Kim Anna J, Werstuck Geoff H
Department of Biochemistry, McMaster University, Hamilton, ON, Canada.
Can J Physiol Pharmacol. 2006 Jan;84(1):39-48. doi: 10.1139/Y05-142.
Recent decades have seen a significant increase in the incidence of diabetes mellitus. The number of individuals with diabetes is projected to reach 300 million by the year 2025. Diabetes is a leading cause of blindness, renal failure, lower limb amputation, and an independent risk factor for atherosclerotic cardiovascular disease (CVD)--a leading cause of death in Western society. Understanding the molecular and cellular mechanisms by which diabetes mellitus promotes atherosclerosis is essential to developing methods to treat and prevent diabetes-associated CVD. This review summarizes our current knowledge of the mechanisms by which diabetes may promote atherogenesis and specifically focuses on a novel pathway linking these 2 conditions. We hypothesize that the accumulation of intracellular glucosamine observed in conditions of chronic hyperglycaemia may promote atherogenesis via a mechanism involving dysregulated protein folding, activation of endoplasmic reticulum (ER) stress, and increased glycogen synthase kinase (GSK)-3 activity. The identification of this novel mechanism provides a promising hypothesis and multiple new targets for potential therapeutic intervention in the treatment of diabetes mellitus and accelerated atherosclerosis.
近几十年来,糖尿病的发病率显著上升。预计到2025年,糖尿病患者人数将达到3亿。糖尿病是导致失明、肾衰竭、下肢截肢的主要原因,也是动脉粥样硬化性心血管疾病(CVD)的独立危险因素,而CVD是西方社会的主要死因。了解糖尿病促进动脉粥样硬化的分子和细胞机制对于开发治疗和预防糖尿病相关CVD的方法至关重要。本综述总结了我们目前对糖尿病可能促进动脉粥样硬化机制的认识,并特别关注连接这两种情况的新途径。我们假设,在慢性高血糖条件下观察到的细胞内氨基葡萄糖积累可能通过涉及蛋白质折叠失调、内质网(ER)应激激活和糖原合酶激酶(GSK)-3活性增加的机制促进动脉粥样硬化。这一新机制的确定为糖尿病和加速动脉粥样硬化的潜在治疗干预提供了一个有前景的假设和多个新靶点。